Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast

British Journal of Cancer

Volumn 77, Issue 9, 1998, Pages 1439-1447

  Marsh, K L ^a   Varley, J M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Ductal carcinoma in situ; Heterogeneity; Loss of heterozygosity; Microdissection

Indexed keywords

PROTEIN P16;

ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; CHROMOSOME 9P; CLINICAL ARTICLE; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; PRIORITY JOURNAL;

EID: 0031918788     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.237     Document Type: Article

References (41)

1. Aldaz CM, Chen T, Sahin A, Cunningham J and Bondy M (1995) Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 55: 3976-3981
2. Barnes DM, Bartkova J, Camplejohn RS, Gullick WJ, Smith PS and Mills RR (1992) Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? Eur J Cancer 28: 644-648
3. Bonsing BA, Devilee P, Cleton-Jansen A-M, Kuipers-Dijkshoorn N, Fleuren GJ and Cornelisse CJ (1993) Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas. Cancer Res 53: 3804-3811
4. Cairns P, Tokino K, Eby Y and Sidransky D (1995). Localisation of tumour suppressor loci on chromosome 9 in primary human renal cell carcinoma. Cancer Res 55: 224-227
5. Callahan R, Cropp C, Sheng ZM, Merlo G, Steeg P, Liscia D and Lidereau R (1993) Definition of regions of the human genome affected by loss of heterozygosity in primary human breast tumors. J Cell Biochem 17G: 167-172
6. Chen LC, Kurisu W, Ljung BM, Goldman ES, Moore D and Smith HS (1992) Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst 84: 506-510
7. Coleman A, Fountain JW, Nobori T, Olopade OI, Robertson G, Housman DE and Lugo TG (1994) Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res 54: 344-348
8. Deng G, Lu Y, Zlotnikov G, Thor AD and Smith HS (1996) Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059
9. Devlin J, Keen AJ and Knowles MA (1994) Homozygous deletion mapping at 9p21 in bladder carcinomas defines a critical region within 2 cM of IFNA: Oncogene 9: 2757-2760
10. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J and Weissenbach J (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites, Nature 380: 152-154
11. Fujii H, Marsh C, Cairns P, Sidransky D and Gabrielson E (1996) Genetic divergence in the clonal evolution of breast cancer. Cancer Res 56: 1493-1497
12. Gruis NA, Van Der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W and Frants RR (1995) Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet 10: 351-353
13. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau C, Marc S, Bernadi G, Lathrop M and Weissenbach J (1994) The 1993-1994 Genethon human genetic linkage map. Nature Genet 7: 246-339
14. Hoggard N, Brintnell B, Howell A, Weissenbach J and Varley J (1995) Allelic imbalance on chromosome 1 in human breast cancer. II. Microsatellite repeat analysis. Genes Chromosom Cancer 12: 24-31
15. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH, Tucker MA and Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nature Genet 8: 15-21
16. Ichimura K, Schmidt EE, Yamaguchi N, James CD and Collins VP (1994) A common region of homozygous deletion in malignant human gliomas lies between the IFNa/w gene cluster and the D9S171 locus. Cancer Res 54: 3127-3130
17. James LA, Mitchell ELD, Menasce L and Varley JM (1997) Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene (in press)
18. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RSI, Johnson BE and Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumour types. Science 264: 436-440
19. Kwiatkowski DJ and Diaz MO (1992) Dinucleotide repeat polymorphism at the IFNA locus (9p22). Hum Mol Genet 1: 658
20. Lagios MD (1993) Heterogeneity of ductal carcinoma in situ of the breast. J Cell Biochem 17G: 49-52
21. Mead LJ, Gillespie MT, Irving LB and Campbell LJ (1994) Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer. Cancer Res 54: 2307-2309
22. Merlo A, Gabrielson E, Mabry M, Vollmer R, Baylin SB and Sidransky D (1994) Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p and 6q in primary human small cell lung cancer. Cancer Res 54: 2322-2326
23. Munn KE, Walker RA and Varley JM (1995) Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 10: 1653-1657
24. Munn KE, Walker RA, Menasce L and Varley JM (1996) Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast. Br J Cancer 73: 636-639
25. Neville EM, Stewart M, Myskow M, Donnelly RJ and Field JK (1995) Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer. Oncogene 11: 581-585
26. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756
27. Olopade OI, Buchhagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD and Diaz MO (1993) Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 53: 2410-2415
28. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE and Cordon-Cardo C (1994) Chromosome 9 allelic losses and microsatellite alterations in human bladder tumours. Cancer Res 54: 2848-2851
29. Ottesen GL, Graversen HP, Blichert TM, Zedeler K and Andersen JA (1992) Ductal carcinoma in situ of the female breast: short-term results of a prospective nationwide study. Am J Surg Pathol 16: 1183-1196
30. Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS and Donis-Keller H (1995) Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res 55: 3399-3405
31. Ruppert JM, Tokino K and Sidransky D (1993) Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53: 5093-5095
32. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning - A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press.
33. Schwartz GF, Finkel GC, Garcia JC and Patchefsky AS (1992) Subclinical ductal carcinoma in situ of the breast. Cancer 70: 2468-2474
34. Serrano M, Hannon GJ and Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707
35. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D and Depinho RA (1996) Role of the INK4a locus in tumour suppression and cell mortality. Cell 85: 27-37
36. Sonada Y, Yashimoto T and Sekiya T (1995) Homozygous deletion of the MTS1/p16 and MTS2/pI5 genes and amplification of the CDK4 gene in glioma. Oncogene 11: 2145-2149
37. Stratton MR and Wooster R (1996) Hereditary predisposition to breast cancer. Curr Opin Genet Dev 6: 93-97
38. Tarmin L, Yin J, Zhou X, Suzuki H, Jiang H-Y, Rhyu M-G, Abraham JM, Krasna MJ, Cottrell J and Meltzer SJ (1994). Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the oesophagus. Cancer Res 54: 6094-6096
39. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G and Lathrop M (1992) A second-generation linkage map of the human genome. Nature 359: 794-801
40. Wilkie PJ, Krizman DB and Weber JL (1992) Linkage map of human chromosome 9 microsatellite polymorphisms. Genomics 12: 607-609
41. Zhuang Z, Merino MJ, Chuaqui R. Liotta LA and Emmert-Buck MR (1995) Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 55: 467-471